Montserrat Torrebadell

5PUBLICATIONS
50CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 28, 2024
Secondary haematological dysplasia after CAR-T-cell therapy for acute lymphoblastic leukaemia in children.

Alexandre Theron, Anna Alonso-Saladrigues, Jose-Luis Dapena

|Mar 23, 2023
A miRNA signature related to stemness identifies high-risk patients in paediatric acute myeloid leukaemia.

Elena Esperanza-Cebollada, Soledad Gómez-González, Sara Perez-Jaume

|Apr 14, 2022
CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies.

Clara Bueno, Susana Barrera, Alex Bataller

|Jan 25, 2019
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01.

Guillem Pascual-Pasto, Miriam Bazan-Peregrino, Nagore G Olaciregui

|Feb 03, 2018
A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia.

Montserrat Torrebadell, Marina Díaz-Beyá, Susana G Kalko

Pageof 1

Frequent Collaborators

3 joint publications

Mireia Camós

3 joint publications

Susana Rives

2 joint publications

Albert Català

2 joint publications

Elena Esperanza-Cebollada